相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Sphingosine-1-phosphate: metabolism, transport, atheroprotection and effect of statin treatment
Patrice Therond et al.
CURRENT OPINION IN LIPIDOLOGY (2022)
What characterizes event-free elderly FH patients? A comprehensive lipoprotein profiling
Torunn Melnes et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2022)
Determination of Serum Progranulin in Patients with Untreated Familial Hypercholesterolemia
Biborka Nadro et al.
BIOMEDICINES (2022)
Clinical Aspects of Genetic and Non-Genetic Cardiovascular Risk Factors in Familial Hypercholesterolemia
Eszter Berta et al.
GENES (2022)
Familial Hypercholesterolemia: Do HDL Play a Role?
Juan Pedro-Botet et al.
BIOMEDICINES (2021)
Potent anti-inflammatory properties of HDL in vascular smooth muscle cells mediated by HDL-S1P and their impairment in coronary artery disease due to lower HDL-S1P: a new aspect of HDL dysfunction and its therapy
Petra Keul et al.
FASEB JOURNAL (2019)
Identifying patients with familial hypercholesterolemia using data mining methods in the Northern Great Plain region of Hungary
Gyorgy Paragh et al.
ATHEROSCLEROSIS (2018)
Decreased serum PON1 arylesterase activity in familial hypercholesterolemia patients with a mutated LDLR gene
Muhammad Idrees et al.
GENETICS AND MOLECULAR BIOLOGY (2018)
High-density lipoprotein-associated sphingosine-1-phosphate activity in heterozygous familial hypercholesterolaemia
Miguel A. Frias et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2017)
HDL cholesterol concentration or HDL function: which matters?
Philip J. Barter et al.
EUROPEAN HEART JOURNAL (2017)
HDL abnormalities in familial hypercholesterolemia: Focus on biological functions
Shiva Ganjali et al.
PROGRESS IN LIPID RESEARCH (2017)
Sphingosine Kinases and Sphingosine 1-Phosphate Receptors: Signaling and Actions in the Cardiovascular System
Alessandro Cannavo et al.
FRONTIERS IN PHARMACOLOGY (2017)
Familial hypercholesterolaemia: cholesterol efflux and coronary disease
Jorie Versmissen et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2016)
HDL Dysfunction Is the Answer in the Sphinx's Riddle?
Juan J. Badimon et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Effect of statin therapy on paraoxonase-1 status: A systematic review and meta-analysis of 25 clinical trials
Gianna Ferretti et al.
PROGRESS IN LIPID RESEARCH (2015)
Searching for a successful HDL-based treatment strategy
Srinivasa T. Reddy et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2014)
Atheroprotective role of high-density lipoprotein (HDL)-associated sphingosine-1-phosphate (S1P)
Francesco Poti et al.
CARDIOVASCULAR RESEARCH (2014)
Strong correlations between circulating chemerin levels and lipoprotein subfractions in nondiabetic obese and nonobese subjects
Hajnalka Lorincz et al.
CLINICAL ENDOCRINOLOGY (2014)
Association of chemerin with oxidative stress, inflammation and classical adipokines in non-diabetic obese patients
Peter Fueloep et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2014)
HDL-targeted therapies: progress, failures and future
Bronwyn A. Kingwell et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Sphingosine-1-Phosphate Receptor-2 Function in Myeloid Cells Regulates Vascular Inflammation and Atherosclerosis
Athanasia Skoura et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Pharmacological relevance and potential of sphingosine 1-phosphate in the vascular system
Mirjam Schuchardt et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms
Mohamad Navab et al.
NATURE REVIEWS CARDIOLOGY (2011)
Proteomic Analysis of Defined HDL Subpopulations Reveals Particle-Specific Protein Clusters Relevance to Antioxidative Function
W. Sean Davidson et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Benefits and Difficulties in Measuring HDL Subfractions and Human Paraoxonase-1 Activity During Statin Treatment
Mariann Harangi et al.
CARDIOVASCULAR DRUGS AND THERAPY (2009)
"Inside-Out" Signaling of Sphingosine-1-Phosphate: Therapeutic Targets
K. Takabe et al.
PHARMACOLOGICAL REVIEWS (2008)
Biomarkers of atherosclerotic plaque instability and rupture
Wolfgang Koenig et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Extracellular export of sphingosine kinase-1a contributes to the vascular S1P gradient
Krishnan Venkataraman et al.
BIOCHEMICAL JOURNAL (2006)
The effect of statin therapy on plasma high-density lipoprotein cholesterol levels is modified by paraoxonase-1 in patients with familial hypercholesterolaemia
TM Van Himbergen et al.
JOURNAL OF INTERNAL MEDICINE (2005)
Antiinflammatory properties of HDL
PJ Barter et al.
CIRCULATION RESEARCH (2004)
分享论文
